News
MONTRÉAL, QUEBEC / ACCESS Newswire / August 15, 2025 / Vision Marine Technologies Inc. (the “Company”, “Vision Marine”, “we”, “us”, “our”) (Nasdaq:VMAR), a leader in high-voltage electric marine ...
While most of AI's power players have already reported, the ultimate industry bellwether, Nvidia (NASDAQ: NVDA), has yet to step up to the plate. The semiconductor giant is scheduled to announce ...
Key Takeaways The S&P 500 was little changed Monday, Aug. 18, 2025, ahead of results from major retailers set for release this week and a key speech by the Federal Reserve chair Friday.Shares of HR ...
The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...
6h
Investor's Business Daily on MSNStock Market Today: Dow, Nasdaq Firm As Trump Teases Putin Move; This New Warren Buffett Stock Rallies Again (Live Coverage)
The Dow Jones fell and Nasdaq edged up. A new Warren Buffett equity rose on the stock market today. President Donald Trump ...
U.S. stocks ended mostly flat on Monday as investors followed the meeting between U.S. President Donald Trump and Ukrainian ...
President Trump's tariffs continue to affect global markets and the economy. Follow for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...
Investors are tracking talks aimed at ending the Russia-Ukraine war and awaiting Federal Reserve Chair Jerome Powell's speech ...
If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world, and his annual ...
13h
Zacks Investment Research on MSNLilly Stock Down 5% This Month: Should You Buy the Dip?
Eli Lilly and Company’s LLY stock has declined 5.1% so far this month, despite announcing strong second-quarter results on Aug. 7. The company beat estimates for both earnings and sales. Sales of ...
Oscar Health is deeply undervalued but faces high short-term uncertainty due to ACA-specific risks. Read why I rate OSCR ...
This high-performing stock has returned over 14,000% over its lifetime and outperformed the S&P 500 over the past one, three, five, and 10 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results